Drug Shortage Report for NAROPIN
Report ID | 209405 |
Drug Identification Number | 02229415 |
Brand name | NAROPIN |
Common or Proper name | ropivacaine HCl 5mg/mL 5x20mL SU Polyamp® Duofit® |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL BLOCK/INFILTRATION BLOCK/INFILTRATION EPIDURAL |
Packaging size | 5 PP Polybag |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-01-15 |
Actual start date | 2024-01-15 |
Estimated end date | 2024-02-20 |
Actual end date | 2024-02-13 |
Shortage status | Resolved |
Updated date | 2024-02-13 |
Company comments | VR89865CA1 NAROPIN 5MG/ML LIQ PP AMP 5X20ML CA ASP |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-02-13 | French | Compare |
v10 | 2024-02-13 | English | Compare |
v9 | 2024-02-05 | French | Compare |
v8 | 2024-02-05 | English | Compare |
v7 | 2024-01-18 | French | Compare |
v6 | 2024-01-18 | English | Compare |
v5 | 2024-01-16 | English | Compare |
v4 | 2023-12-12 | French | Compare |
v3 | 2023-12-12 | English | Compare |
v2 | 2023-11-06 | French | Compare |
v1 | 2023-11-06 | English | Compare |
Showing 1 to 11 of 11